Home » Regeneron

Regeneron

Jun 27, 2016

Regeneron, Scandanavian Schools to Study Genetics of Diabetes

In the study, the partners will perform exome sequencing and whole-genome array genotyping on more than 9,000 individuals with diabetes or with diabetic relatives.

May 26, 2016

Regeneron Searches for Talent

Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.

May 02, 2016

Geisinger MyCode Results, Reengagement of Patients May Clarify Variant Pathogenicity, Penetrance

Premium

Geisinger Health System's MyCode Community Health Initiative has signed up more than 100,000 participants and has returned results to about 100 patients.

Apr 12, 2016

Intellia Files for $120M IPO, Inks Lucrative Collaboration With Regeneron

The CRISPR/Cas9 therapeutics firm could reap billions from the Regeneron collaboration, which includes $75 million up front and a $50 million private placement.

Mar 03, 2016

Teams Describe Mutations Tied to Lower Triglyceride Levels, Reduced Coronary Artery Disease Risk

Independent research groups garnered evidence that mutations to the ANGPTL4 gene can lower blood triglyceride levels and reduce coronary artery disease risk.

Nov 24, 2015

Regeneron Licenses CRISPR-Cas9 IP From ERS Genomics

ERS Genomics was founded to provide broad access to CRISPR-Cas9 intellectual property, which is based on the research of Emmanuelle Charpentier.

May 13, 2015

Jumping into Genomics for Drug Discovery

Drug companies are rushing toward genomic databases to inform their searches for new drugs, Reuters reports.

Mar 17, 2015

Q&A: Regeneron's Aris Baras and Alan Shuldiner on Large-Scale Sequencing for Drug Discovery

Premium
Alan Shuldiner, Aris Baras

Two executives of the Regeneron Genetics Center discuss the company's strategy for employing sequencing-based human genetics in drug discovery and development.

Mar 17, 2015

With 30,000 Exomes and Counting, Regeneron Adds Large-Scale Targeted Sequencing Projects

Regeneron Pharmaceuticals

Equipped with 10 Illumina HiSeq 2500s and one PacBio RSII, the Regeneron Genetics Center cranks out more than 1,200 exomes per week.

Oct 16, 2014

Regeneron Genetics Center Inks Research Partnerships with Columbia, Baylor, Clinic for Special Children

NEW YORK (GenomeWeb) – The Regeneron Genetics Center, a wholly-owned subsidiary of Regeneron Pharmaceuticals, has partnered with Columbia University Medical Center, the Clinic for Special Children, and Baylor College of Medicine to study a variety of Mendelian diseases.

Pages

The Scan

WHO Panel Announced

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

Research Reproducibility Scores

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Tests for All Diagnosed

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

This Week in Science

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.